Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature
- PMID: 17443359
- PMCID: PMC2219737
- DOI: 10.1007/s11606-007-0189-1
Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature
Abstract
We report a case of a 62-year-old woman with renal cell carcinoma (RCC) presenting with a hypercalcemia-induced coma. A laboratory evaluation indicated nonparathyroid-mediated hypercalcemia with an initial serum calcium level of 18.6 mg/dL. Our patient's parathyroid hormone (PTH)-related peptide level was undetectable. Initial imaging was negative, but PET scan identified a mass in the upper pole of the left kidney. Our patient underwent partial nephrectomy, and the mass was identified as RCC on final pathology. After surgery, her hypercalcemia resolved and PTH returned to normal limits. This case report describes a patient with RCC with the unusual presentation of hypercalcemic coma. We review the differential diagnosis of malignant hypercalcemia and the evaluation of hypercalcemia occurring with RCC. This case illustrates the need to carefully review and interpret all available data, especially when conventional testing in the work-up of hypercalcemia is unrevealing.
Figures



Similar articles
-
The coexistence of renal cell carcinoma and diffuse large B-cell lymphoma with hypercalcemic crisis as the initial presentation.Endocr Regul. 2014 Jul;48(3):113-9. doi: 10.4149/endo_2014_03_113. Endocr Regul. 2014. PMID: 25110209
-
Hypercalcemia of malignancy associated with renal cell carcinoma in a dog.J Am Anim Hosp Assoc. 2013 Nov-Dec;49(6):385-8. doi: 10.5326/JAAHA-MS-5895. Epub 2013 Jul 16. J Am Anim Hosp Assoc. 2013. PMID: 23861266
-
Hypercalcemia in patients with metastatic renal cell carcinoma: effect of nephrectomy and metabolic evaluation.J Urol. 1997 Sep;158(3 Pt 1):733-9. doi: 10.1097/00005392-199709000-00011. J Urol. 1997. PMID: 9258070
-
Bisphosphonate treatment of tumor-induced hypercalcemia in a toddler: case report and review of related literature.Endocr Pract. 2006 Nov-Dec;12(6):670-5. doi: 10.4158/EP.12.6.670. Endocr Pract. 2006. PMID: 17229665 Review.
-
Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.World J Urol. 2018 Jun;36(6):849-854. doi: 10.1007/s00345-018-2215-9. Epub 2018 Feb 10. World J Urol. 2018. PMID: 29429069 Review.
Cited by
-
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.Can Urol Assoc J. 2021 Apr;15(4):132-137. doi: 10.5489/cuaj.6833. Can Urol Assoc J. 2021. PMID: 33007184 Free PMC article.
-
Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.Cureus. 2021 Jul 29;13(7):e16718. doi: 10.7759/cureus.16718. eCollection 2021 Jul. Cureus. 2021. PMID: 34513354 Free PMC article.
-
Animal Models of Cancer-Associated Hypercalcemia.Vet Sci. 2017 Apr 13;4(2):21. doi: 10.3390/vetsci4020021. Vet Sci. 2017. PMID: 29056680 Free PMC article. Review.
-
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.World J Urol. 2016 Oct;34(10):1465-72. doi: 10.1007/s00345-016-1793-7. Epub 2016 Feb 25. World J Urol. 2016. PMID: 26914818
-
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma.Cancer Cell. 2014 Nov 10;26(5):738-53. doi: 10.1016/j.ccell.2014.09.015. Epub 2014 Nov 10. Cancer Cell. 2014. PMID: 25517751 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '17045081', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17045081/'}]}
- McLaughlin J, Lipworth L, Tarone R. Epidemiologic aspects of renal cell carcinoma. Semin Oncol. 2006;33(5):527–33. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10235157', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10235157/'}]}
- Chow W, Devesa S, Warren J, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628–31. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16339096', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16339096/'}]}
- Cohen H, McGovern F. Renal-cell carcinoma. N Engl J Med. 2005;353(23)2477–90. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2288659', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2288659/'}]}
- Zagoria R, Dyer R, Wolfman N, Hinn G, Chen Y. Radiology in the diagnosis and staging of renal cell carcinoma. Crit Rev Diagn Imaging. 1990;31(1):81–115. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15564390', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15564390/'}]}
- Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: detection with dual-modality PET/CT—initial experience. Radiology. 2005;234(1):227–34. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical